Skip to main content
Log in

Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency

  • Immunology/Allergology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

We report a 2.3-year-old girl with complete lack of adenosine deaminase (ADA) activity who presented with severe atopic dermatitis and insulin-dependent diabetes mellitus but only mild recurrent infections. Abnormalities of immune function included profound depletion of CD8+ lymphocytes, hyperimmunoglobulinaemia E, and very low in vitro proliferative response to mitogens. Treatment with polyethylene glycol-conjugated ADA was followed by rapid amelioration of clinical and immunological conditions. The immunological and clinical features of this child suggest that the clinical spectrum of ADA deficiency may be broader than originally supposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ADA:

adenosine deaminase

IDDM:

insulin-dependent diabetes mellitus

PEG-ADA:

polyethylene glycol-modified ADA

PNP:

purine nucleoside phospharylase

SCID:

severe combined immunodeficiency

TCR:

T-cell antigen receptor

References

  1. Ammann AJ, Cowan MS, Martin DW, Wara DW (1983) Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. Birth Defects 19:117–120

    PubMed  Google Scholar 

  2. Bellgrau D, Lagarde AC (1990) Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implication for generation of an autoimmune T-cell repertoire. Proc Natl Acad Sci USA 87:313–317

    PubMed  Google Scholar 

  3. Borst J, Van Dongen JJM, De Vries E, Comans-Bitter WM, Van Tol MJD, Vossen JM, Kurrle R (1990) BMA031, a monoclonal antibody specifically suited to identify the T cell receptor αβ/CD3 complex on viable human T lymphocytes in normal and disease states. Hum Immunol 29:175–188

    Article  PubMed  Google Scholar 

  4. Carbonari M, Cherchi M, Paganelli R (1990) Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med 322:73–76

    PubMed  Google Scholar 

  5. Cederbaum SD, Kaitila L, Rimoin DL, Stiehm ER (1976) The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr 89:737–742

    PubMed  Google Scholar 

  6. Cowan MS, Smith W, Ammann AJ (1989) Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency. Clin Immunol Immunopathol 53:59–67

    Article  PubMed  Google Scholar 

  7. Ferrari G, Rossini S, Giavazzi R, Maggioni D, Nobili N, Soldati M, Ungers G, Mavilio F, Gilboa E, Bordingnon C (1991) An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 251:1363–1366

    PubMed  Google Scholar 

  8. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky R, Vossen J (1990) European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet II:850–854

    Article  Google Scholar 

  9. Geffner ME, Stiehn ER, Stephure D, Cowan MJ (1986) Probable autoimmune thyroid disease and combined immunodeficiency disease. Am J Dis Child 140:1194–1196

    PubMed  Google Scholar 

  10. Gene therapy begins [News] (1990) Science 294: 1372

    Google Scholar 

  11. Georgiou HM, Lagarde AC, Bellgrau D (1988) T cell dysfunction in the diabetes-prone BB rat. A role for thymic migrants that are not T cell precursors. J Exp Med 167:132–148

    Article  PubMed  Google Scholar 

  12. Giblett ER, Anderson JE, Cohen H, Pollara B, Meuwissen HJ (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet II:1067–1069

    Article  Google Scholar 

  13. Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Schiff R, Hatem C, Kurtzberg J, Markert ML, Kobayashi RH, Kobayashi AL, Abuchowski A (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA). N Engl J Med 316:589–596

    PubMed  Google Scholar 

  14. Hirschhorn ER (1977) Defects of purine metabolism in immunodeficiency diseases. Progr Clin Immunol 3:67–83

    Google Scholar 

  15. Hirschhorn R (1983) Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy. In: Wedgwood RJ, Rosen FS, Paul NW (eds) Primary immunodeficiency diseases. Alan R Liss, New York, pp 73–81

    Google Scholar 

  16. Hirschhorn R (1986) Inherited enzyme deficiencies and immunodeficiency: Adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies. Clin Immunol Immunopathol 40:157–165

    Article  PubMed  Google Scholar 

  17. Hirschhorn R, Ellenbogen A (1987) Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency. Am J Hum Genet 38:13–25

    Google Scholar 

  18. Hirschhorn R, Papageorgiou PS, Kesariwala HH, Taft LT (1980) Amelioration of neurologic abnormalities after “enzyme replacement” in adenosine deaminase deficiency. N Engl J Med 303:377–380

    PubMed  Google Scholar 

  19. Hirschhorn R, Tzall S, Ellenbogen A (1990) Hot spot point mutations in adenosine deaminase deficiency. Proc Natl Acad Sci USA 87:6171–6175

    PubMed  Google Scholar 

  20. Jenkins T, Rabson AR, Nurse GT, Lane AB, Hopkinson DA (1976) Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J Pediatr 89:732–736

    PubMed  Google Scholar 

  21. Kredich NM, Hershfield MS (1989) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. Mc Gray Hill, New York, pp. 1045–1075

    Google Scholar 

  22. Kurlandsky LE (1988) Hyperimmunoglobulinemia E in a child with partial adenosine deaminase (ADA) deficiency. Pediatr Res 23:356A

    Google Scholar 

  23. Levy Y, Fernandez Mejia C, Hershfield MS, Polmar SH, Sudiery D, Berger M, Sorensen RU (1988) Adenosine deaminase (ADA) deficiency in a patient with late onset of recurrent infections: response to polyethylene glycol (PEG) modified ADA treatment. Pediatr Res 23:356A

    Google Scholar 

  24. Linch DC, Levinsky RJ, Rodeck CH, Mac Lennan KA, Simmonds HA (1984) Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency. Clin Exp Immunol 56:222–228

    Google Scholar 

  25. Markert ML, Norby-Slycord C, Ward FE (1989) A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution. Am J Hum Genet 45:354–361

    PubMed  Google Scholar 

  26. Maruta K, Treichel U, Kolb-Bachofen V, Kolb H (1989) Prospective analysis of eosinophilia in spontaneously diabetic BB rats: correlation with islet inflammation but not with diabetes development. Diabetes Res 11:173–176

    PubMed  Google Scholar 

  27. Morgan G, Levinsky RJ, Hugh-Jones K, Fairbanks LD, Morris GS, Simmonds HA (1987) Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Clin Exp Immunol 70:491–499

    PubMed  Google Scholar 

  28. Ratech H, Greco MA, Gallo G, Rimoin DI, Kamino H, Hirschhorn R (1985) Pathologic findings in adenosine-deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations. Am J Pathol 120:157–168

    PubMed  Google Scholar 

  29. Ratech H, Hirschhorn R, Greco MA (1989) Pathological findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations. Am J Pathol 135:1145–1156

    PubMed  Google Scholar 

  30. Rossini AA, Mordes JP, Greiner DL (1990) The pathogenesis of autoimmune diabetes mellitus. Curr Opin Immunol 2:598–603

    Article  Google Scholar 

  31. Simmonds HA, Fairbanks LD, Morris GS, Webster DR, Harley EH (1988) Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine and pyrimidine metabolism. Clin Chim Acta 171:197–210

    PubMed  Google Scholar 

  32. Wilson DK, Rudolph FB, Quiocho FA (1991) Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science 252:1278–1284

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Notarangelo, L.D., Stoppoloni, G., Toraldo, R. et al. Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency. Eur J Pediatr 151, 811–814 (1992). https://doi.org/10.1007/BF01957930

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01957930

Key words

Navigation